Subscribe To Our Free Newsletter |
Granules India gains after receiving US FDA nod for gout medicine
Granules India advanced 1.59% to Rs 426.90 after the company announced that the US Food & Drug Administration (US FDA) has approved its abbreviated new drug application (ANDA) for Colchicine Capsules.